The Absorption, Metabolism and Excretion of [14C]CM082 in Human

Clinical trial NCT04434326 · COMPLETED

Trial details

NCT number: NCT04434326
Sponsor: AnewPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2021-07-05
Primary completion: 2021-10-22
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.